Questionnaire for data collection
Person in charge of human xenotransplantation practice.
Title : Professor.
First Name: Patrick
Last name : Aebischer
Address :
Zip :
State : Lausanne
Country : Switzerland
Institution : University of Lausanne Medical School
Telephone :
Email :
What is the source of your information about human xenotransplantation practices?
Publication
What is the therapeutic purpose of this xenotransplantation treatment?
Chronic pain
Where and when is this human xenotransplantation practice taking place?
Country Switzerland
Timing In 1996
Is this treatment part of a clinical trial?
Yes
How many patients are included in this clinical trial?
7
What are the inclusion criteria for patient selection?
i. Duration on the waiting list? unknown
ii. Life-threatening diseases without alternative therapy? No
iii. Is a protocol available? Yes
If yes, could you please send a copy?
What is the animal source of the xenotransplantation product?
Calf
Source animals Do you have information about source animals? No
Testing of safety : Do you have information about testing of safety? No
What type of cells/tissues/organs was transplanted?
Cells:
Tissues:
Organs:
Others:
Chromaffin cells
What type of exposure to xenogeneic cells was involved?
Solid-organ xenotransplantation: No
Cellular xenotransplantation: Yes
Tissue xenotransplantation: No
Human cells exposed to xenogeneic Feeder cell: No
Extracorporeal perfusion: No
Encapsulation: Yes
Other bioartificial isolation device:
Others:
Transplant Do you have information about transplant recipients? No
Have results been presented at a scientific congress?
Unknown
if yes, where?
Have results been published in a scientific journal?
Yes
if yes, where?
Buchser E. et al. Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience Anesthesiology 1996 Nov;85(5):1005-12
Is this human clinical trial performed with governmental and/or institutional oversight and supervision?
Yes
if yes, which?
Ethical Committee of the Faculty of Medicine at the University of Lausanne, Switzerland
Was the trial approved by a public health authorities(ministry of health, governmental agency...)?
Unknown
if yes, which?
Was the trial overseen by a public health authorities(ministry of health, governmental agency...)?
Unknown
if yes, which?
Comment